Elevated levels of Bmi1 are associated with a poor prognosis in patients with head and neck cancer, nasopharyngeal carcinoma, and glioma.47, 48, 49, 50, 51, 52, 53. This evidence concerns the gene BMI1 and nasopharyngeal carcinoma.